Clinical Trial Update: Miltefosine Plus IL Pentamidine for Bolivian CL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating miltefosine in combination with intralesional pentamidine for cutaneous leishmaniasis in Bolivia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)
• Pentamidine (intralesional) (pentamidine)

Snippet

Sponsor: Jonathan Berman | Conditions: Leishmaniasis, Cutaneous | Phase 2 | Status: COMPLETED